Investments in Joint Ventures and Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2015

Equity Method Investments and Joint Ventures [Abstract]

Summary of Carrying Amounts of Assets and Fair Value of Liabilities Included in Condensed Consolidated Balance Sheet and Maximum Loss Exposure in VIE

The following table summarizes the carrying amounts of the assets and the fair value of the liabilities included in the Company’s consolidated balance sheets and the maximum loss exposure related to the Company’s interest in the Solazyme Bunge JV as of December 31, 2015 and 2014 (in thousands):



	As of December 31, 2015
	Assets						Liabilities
VIE	Accounts Receivable		Unbilled Revenues		Investments in Unconsolidated Joint Ventures		Loan Guarantee		Maximum Exposure to Loss⁽¹⁾
Solazyme Bunge JV	$	12	$	839	$	35,910	$	—	$	45,692



	As of December 31, 2014
	Assets						Liabilities
VIE	Accounts Receivable		Unbilled Revenues		Investments in Unconsolidated Joint Ventures		Loan Guarantee		Maximum Exposure to Loss⁽²⁾
Solazyme Bunge JV	$	446	$	2,435	$	40,934	$	—	$	57,618


⁽¹⁾	Includes maximum exposure to loss attributable to the Company’s bank guarantee required to be provided for the Solazyme Bunge JV of $8.9 million (based on the exchange rate at December 31, 2015).

⁽²⁾Includes maximum exposure to loss attributable to the Company’s bank guarantee required to be provided for the Solazyme Bunge JV of $13.2 million and non-cancelable purchase obligations of $0.6 million (based on the exchange rate at December 31, 2014).

Summarized Information on Solazyme Bunge JV's Balance Sheets and Income Statements

Summarized information on the Solazyme Bunge JV’s balance sheets and income statements as of December 31, 2015, 2014 and 2013 and for the years ended December 31, 2015, 2014 and 2013, respectively, was as follows (in thousands):



	As of December 31, 2015		As of December 31, 2014
Current assets	$	5,654	$	4,339
Property, plant and equipment, net	100,755		141,147
Recoverable taxes⁽¹⁾	16,144		20,604
Total assets	$	122,553	$	166,090

Current liabilities	$	23,009	$	24,881
Noncurrent liabilities	43,054		78,666
JV’s partners’ capital, net	56,490		62,543
Total liabilities and partners’ capital, net	$	122,553	$	166,090

⁽¹⁾Recoverable taxes are comprised of value-added taxes paid upon the acquisition of property, plant and equipment items and other goods and services, and other transactional taxes which can be recovered in cash or as compensation against income taxes or other taxes owed by Solazyme Bunge JV in Brazil. The realization of these recoverable tax payments could take in excess of five years.



	Year ended December 31, 2015			Year ended December 31, 2014			Year ended December 31, 2013
Net sales	$	3,713		$	805		$	—
Net losses	$	(42,398	)	$	(46,165	)	$	(16,280	)

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details